NFE2L2 and metabolic syndrome: In addition to well-established disease groups, NRF2 signalling has also been implicated in several heterogeneous conditions such as metabolic syndrome, cholestatic liver injury, vitiligo, and autism spectrum disorder [[76], [77], [78], [79], [80]].